You are here

patents

Apple vs. AliveCor and the Evolution of Wearable Medical Devices

Apple vs. AliveCor and the Evolution of Wearable Medical Devices

Medical Devices and Diagnostics Industry

Flag link:

FTC says patent battle over Parkinson's drug could have 'significant implications' for patients

FTC says patent battle over Parkinson's drug could have 'significant implications' for patients

Endpoints

Parkinson's Disease

Supernus Pharmaceuticals

Flag link:

Merck, Viatris agree to settle patent feud surrounding diabetes drugs

Merck, Viatris agree to settle patent feud surrounding diabetes drugs

Endpoints

Flag link:

Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim

Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim

Fierce Pharma

Flag link:

Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri

Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri

Fierce Pharma

multiple sclerosis

Flag link:

Warren urges US patent office to scrutinize Merck's efforts with Keytruda

Warren urges US patent office to scrutinize Merck's efforts with Keytruda

Fierce Pharma

Elizabeth Warren

Flag link:

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

BioPharma Dive

Bristol Myers Squibb

Flag link:

Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties

Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties

Fierce Pharma

Mitsubishi Chemical

multiple sclerosis

Flag link:

Daiichi Sankyo gets US patent office to restart review of Seagen patent

Daiichi Sankyo gets US patent office to restart review of Seagen patent

Endpoints

Flag link:

Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case

Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case

Fierce Pharma

Flag link:

US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case

US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case

Endpoints

Flag link:

The end of the Humira era

The end of the Humira era

EP Vantage

Flag link:

In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'

In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'

Endpoints

Flag link:

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Bristol Myers Squibb

Flag link:

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Endpoints

multiple sclerosis

Flag link:

Masimo Takes a Bite Out of Apple

Masimo Takes a Bite Out of Apple

Medical Devices and Diagnostics Industry

Flag link:

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Fierce Pharma

Flag link:

Astellas loses bid to block Lexiscan generics in US

Astellas loses bid to block Lexiscan generics in US

Pharmaphorum

Flag link:

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support

Endpoints

Flag link:

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

AZ wins patent fight with Viatris, gains more exclusivity for blockbuster Symbicort

Fierce Pharma

Flag link:

Pages